| 141 |
Design and synthesis of new 1, 2, 4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors |
قسم الكيمياء العضوية الصيدلية |
2024 |
| 142 |
Design and synthesis of New dihydropyrimidine/sulphonamide hybrids as promising anti-inflammatory agents via dual mPGES-1/5-LOX inhibition |
قسم الكيمياء العضوية الصيدلية |
2024 |
| 143 |
Design and synthesis of novel quinoline-ester/-amide derivatives as potent antiproliferative agent targeting EGFR and BRAFV600E kinases |
قسم الكيمياء العضوية الصيدلية |
2024 |
| 144 |
Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives |
قسم الكيمياء العضوية الصيدلية |
2024 |
| 145 |
Design, synthesis, and antiproliferative activity of new 1, 2, 3-triazole/quinazoline-4-one hybrids as dual EGFR/BRAF V600E inhibitors |
قسم الكيمياء العضوية الصيدلية |
2024 |
| 146 |
Design, synthesis, and antiproliferative activity of new indole/1,2,4-triazole/chalcone hybrids as EGFR and/or c-MET inhibitors |
قسم الكيمياء العضوية الصيدلية |
2024 |
| 147 |
Design, synthesis, and apoptotic antiproliferative action of new 1,2,3-triazole/1,2,4-oxadiazole hybrids as dual EGFR/VEGFR-2 inhibitors |
قسم الكيمياء العضوية الصيدلية |
2024 |
| 148 |
Design, synthesis, and biological evaluation of novel quinoline-based EGFR/HER-2 dual-target inhibitors as potential antitumor agents |
قسم الكيمياء العضوية الصيدلية |
2024 |
| 149 |
Design, synthesis, and molecular docking of novel 1,3, 4-triaryl pyrazole derivatives bearing methylsulfonyl moiety with anticancer activity through dual targeting CDK2 and COX-2 enzymes |
قسم الكيمياء الدوائية |
2024 |
| 150 |
Design, synthesis, biological evaluation and docking study of some new aryl and heteroaryl thiomannosides as FimH antagonists. |
قسم الكيمياء العضوية الصيدلية |
2024 |
